Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the “French Canadian Mutation”

This publication has 37 references indexed in Scilit:

• Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
  Journal of Clinical Investigation, 1994
• Heroic gene surgery
  Nature Genetics, 1994
• Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: The role of posttranscriptional control
  Somatic Cell and Molecular Genetics, 1992
• mRNA quantitation by a simple and sensitive RNAse protection assay
  Genetic Analysis: Biomolecular Engineering, 1991
• Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia
  European Journal of Pediatrics, 1990
• Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• Regulation of the mevalonate pathway
  Nature, 1990
• Identification of a second “French Canadian” LDL receptor gene deletion and development of a rapid method to detect both deletions
  Clinical Genetics, 1989
• Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial Hypercholesterolemia
  New England Journal of Medicine, 1987